Overview

On Demand Contraception: Ulipristal Acetate Plus a COX-2 Inhibitor at Peak Fertility

Status:
Completed
Trial end date:
2019-05-31
Target enrollment:
Participant gender:
Summary
This is an exploratory prospective study investigating if addition of a COX-2 inhibitor can increase efficacy of ulipristal in disrupting ovulation at peak fertility.
Phase:
Phase 1
Details
Lead Sponsor:
Stanford University
Treatments:
Cyclooxygenase 2 Inhibitors
Meloxicam
Ulipristal acetate